The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period. The increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market are the primary growth factors for this market. Also, the increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services are expected to offer significant opportunities for market growth in the coming years. However, the requirement of high capital investments and data management issue is expected to restrain market growth to a certain extent.
The RNA analysis/transcriptomics market is consolidated at the top with a large number of leading market players based in developed countries. The prominent players operating in this market Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Fluidigm Corporation (US), Eurofins Scientific (Germany), Sequentia Biotech SL (Spain), Acobiom (France), GenXPro GmbH (Germany), CD Genomics (US), Promega Corporation (US), Lexogen GmbH (Austria), Cenix BioScience GmbH (Germany), Takara Holdings, Inc. (Japan), bioMérieux SA (France), and LC Sciences LLC (US). However, in the last few years, a number of smaller players have emerged from niche markets, and are competing with global players based on price and technological innovation. Due to the intense competition in the market, major market players are increasingly focusing on expanding their geographic presence into the high-growth emerging markets and strengthening their technological competitiveness in the market by acquiring smaller players with the desired technological capabilities or geographic presence.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific is one of the leading players in the RNA analysis/transcriptomics market. The company is known for its diversified product offerings in the transcriptomics arena ranging from protein expression, purification and isolation kits; electrophoresis instruments and reagents; protein assays and analysis; labeling and crosslinking; mass spectrometry instruments; and protein purification & analytics interactive tools along with a wide range of customization services. Owing to its strong sales and distribution network, the company has a significant global footprint. Additionally, the large number of production sites gives it a competitive advantage over other players in the RNA analysis market.
Agilent Technologies is a global player in the RNA analysis/transcriptomics market, with wide geographic coverage. The company has maintained its leadership position in the market through its strong distribution networks across North America, Europe, and the Asia Pacific. The company offers a wide range of transcriptomics solutions for the life science industry.
Merck offers an exhaustive portfolio of consumables, reagents, analytical laboratory services, and instruments for chromatography, mass spectrometry, and protein quantitation solutions. The company is one of the major players in the spectrometry, reagent, and consumables markets. With a strong brand name and wide geographic coverage in more than 60 countries, Merck has a well-established presence in this market. As a part of its global growth strategy, the company is investing in the fast-growing life science industry by entering into synergies with companies like Sigma-Aldrich.
RNA Analysis/Transcriptomics Market by Product (Reagents, Instruments, Software), By Technology (Microarrays, NGS, Sanger), By Application (Clinical Diagnostics, Drug Discovery), By End User (CROs, Hospitals), COVID-19 Impact - Global Forecast to 2025
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE